The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
IVD-Global Market Insights and Sales Trends 2024
Synopsis
In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
The global IVD market size is expected to reach US$ 8693.1 million by 2029, growing at a CAGR of 2.7% from 2023 to 2029. The market is mainly driven by the significant applications of IVD in various end use industries. The expanding demands from the Diabetes, Infectious Diseases, Oncology/Cancer and Cardiology, are propelling IVD market. Immuno Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemistry Diagnostics segment is estimated at % CAGR for the next seven-year period.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for IVD, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global IVD market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global IVD market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, IVD sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of IVD covered in this report include Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Siemens, Sysmex, Thermo Fisher Scientific, Becton, Dickinson and Company, Biomérieux Sa and Bio-Rad Laboratories, etc.
The global IVD market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostics
Danaher Corporation
Abbott Laboratories
Siemens
Sysmex
Thermo Fisher Scientific
Becton, Dickinson and Company
Biomérieux Sa
Bio-Rad Laboratories
Johnson & Johnson
Agilent Technologies
Qiagen
Diasorin
Ortho Clinical Diagnostics
Global IVD market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global IVD market, Segment by Type:
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Others
Global IVD market, by Application
Diabetes
Infectious Diseases
Oncology/Cancer
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing/Pharmacogenomics
HIV/AIDS
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of IVD companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
The global IVD market size is expected to reach US$ 8693.1 million by 2029, growing at a CAGR of 2.7% from 2023 to 2029. The market is mainly driven by the significant applications of IVD in various end use industries. The expanding demands from the Diabetes, Infectious Diseases, Oncology/Cancer and Cardiology, are propelling IVD market. Immuno Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Chemistry Diagnostics segment is estimated at % CAGR for the next seven-year period.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for IVD, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global IVD market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global IVD market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, IVD sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of IVD covered in this report include Roche Diagnostics, Danaher Corporation, Abbott Laboratories, Siemens, Sysmex, Thermo Fisher Scientific, Becton, Dickinson and Company, Biomérieux Sa and Bio-Rad Laboratories, etc.
The global IVD market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostics
Danaher Corporation
Abbott Laboratories
Siemens
Sysmex
Thermo Fisher Scientific
Becton, Dickinson and Company
Biomérieux Sa
Bio-Rad Laboratories
Johnson & Johnson
Agilent Technologies
Qiagen
Diasorin
Ortho Clinical Diagnostics
Global IVD market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global IVD market, Segment by Type:
Immuno Diagnostics
Chemistry Diagnostics
Molecular Diagnostics
POCT
Others
Global IVD market, by Application
Diabetes
Infectious Diseases
Oncology/Cancer
Cardiology
Nephrology
Autoimmune Diseases
Drug Testing/Pharmacogenomics
HIV/AIDS
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of IVD companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of IVD
1.1 IVD Market Overview
1.1.1 IVD Product Scope
1.1.2 IVD Market Status and Outlook
1.2 Global IVD Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global IVD Market Size by Region (2018-2029)
1.4 Global IVD Historic Market Size by Region (2018-2023)
1.5 Global IVD Market Size Forecast by Region (2024-2029)
1.6 Key Regions, IVD Market Size (2018-2029)
1.6.1 North America IVD Market Size (2018-2029)
1.6.2 Europe IVD Market Size (2018-2029)
1.6.3 Asia-Pacific IVD Market Size (2018-2029)
1.6.4 Latin America IVD Market Size (2018-2029)
1.6.5 Middle East & Africa IVD Market Size (2018-2029)
2 IVD Market by Type
2.1 Introduction
2.1.1 Immuno Diagnostics
2.1.2 Chemistry Diagnostics
2.1.3 Molecular Diagnostics
2.1.4 POCT
2.1.5 Others
2.2 Global IVD Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global IVD Historic Market Size by Type (2018-2023)
2.2.2 Global IVD Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America IVD Revenue Breakdown by Type (2018-2029)
2.3.2 Europe IVD Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific IVD Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America IVD Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa IVD Revenue Breakdown by Type (2018-2029)
3 IVD Market Overview by Application
3.1 Introduction
3.1.1 Diabetes
3.1.2 Infectious Diseases
3.1.3 Oncology/Cancer
3.1.4 Cardiology
3.1.5 Nephrology
3.1.6 Autoimmune Diseases
3.1.7 Drug Testing/Pharmacogenomics
3.1.8 HIV/AIDS
3.1.9 Others
3.2 Global IVD Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global IVD Historic Market Size by Application (2018-2023)
3.2.2 Global IVD Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America IVD Revenue Breakdown by Application (2018-2029)
3.3.2 Europe IVD Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific IVD Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America IVD Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa IVD Revenue Breakdown by Application (2018-2029)
4 IVD Competition Analysis by Players
4.1 Global IVD Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in IVD as of 2022)
4.3 Date of Key Players Enter into IVD Market
4.4 Global Top Players IVD Headquarters and Area Served
4.5 Key Players IVD Product Solution and Service
4.6 Competitive Status
4.6.1 IVD Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche Diagnostics
5.1.1 Roche Diagnostics Profile
5.1.2 Roche Diagnostics Main Business
5.1.3 Roche Diagnostics IVD Products, Services and Solutions
5.1.4 Roche Diagnostics IVD Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Diagnostics Recent Developments
5.2 Danaher Corporation
5.2.1 Danaher Corporation Profile
5.2.2 Danaher Corporation Main Business
5.2.3 Danaher Corporation IVD Products, Services and Solutions
5.2.4 Danaher Corporation IVD Revenue (US$ Million) & (2018-2023)
5.2.5 Danaher Corporation Recent Developments
5.3 Abbott Laboratories
5.3.1 Abbott Laboratories Profile
5.3.2 Abbott Laboratories Main Business
5.3.3 Abbott Laboratories IVD Products, Services and Solutions
5.3.4 Abbott Laboratories IVD Revenue (US$ Million) & (2018-2023)
5.3.5 Siemens Recent Developments
5.4 Siemens
5.4.1 Siemens Profile
5.4.2 Siemens Main Business
5.4.3 Siemens IVD Products, Services and Solutions
5.4.4 Siemens IVD Revenue (US$ Million) & (2018-2023)
5.4.5 Siemens Recent Developments
5.5 Sysmex
5.5.1 Sysmex Profile
5.5.2 Sysmex Main Business
5.5.3 Sysmex IVD Products, Services and Solutions
5.5.4 Sysmex IVD Revenue (US$ Million) & (2018-2023)
5.5.5 Sysmex Recent Developments
5.6 Thermo Fisher Scientific
5.6.1 Thermo Fisher Scientific Profile
5.6.2 Thermo Fisher Scientific Main Business
5.6.3 Thermo Fisher Scientific IVD Products, Services and Solutions
5.6.4 Thermo Fisher Scientific IVD Revenue (US$ Million) & (2018-2023)
5.6.5 Thermo Fisher Scientific Recent Developments
5.7 Becton, Dickinson and Company
5.7.1 Becton, Dickinson and Company Profile
5.7.2 Becton, Dickinson and Company Main Business
5.7.3 Becton, Dickinson and Company IVD Products, Services and Solutions
5.7.4 Becton, Dickinson and Company IVD Revenue (US$ Million) & (2018-2023)
5.7.5 Becton, Dickinson and Company Recent Developments
5.8 Biomérieux Sa
5.8.1 Biomérieux Sa Profile
5.8.2 Biomérieux Sa Main Business
5.8.3 Biomérieux Sa IVD Products, Services and Solutions
5.8.4 Biomérieux Sa IVD Revenue (US$ Million) & (2018-2023)
5.8.5 Biomérieux Sa Recent Developments
5.9 Bio-Rad Laboratories
5.9.1 Bio-Rad Laboratories Profile
5.9.2 Bio-Rad Laboratories Main Business
5.9.3 Bio-Rad Laboratories IVD Products, Services and Solutions
5.9.4 Bio-Rad Laboratories IVD Revenue (US$ Million) & (2018-2023)
5.9.5 Bio-Rad Laboratories Recent Developments
5.10 Johnson & Johnson
5.10.1 Johnson & Johnson Profile
5.10.2 Johnson & Johnson Main Business
5.10.3 Johnson & Johnson IVD Products, Services and Solutions
5.10.4 Johnson & Johnson IVD Revenue (US$ Million) & (2018-2023)
5.10.5 Johnson & Johnson Recent Developments
5.11 Agilent Technologies
5.11.1 Agilent Technologies Profile
5.11.2 Agilent Technologies Main Business
5.11.3 Agilent Technologies IVD Products, Services and Solutions
5.11.4 Agilent Technologies IVD Revenue (US$ Million) & (2018-2023)
5.11.5 Agilent Technologies Recent Developments
5.12 Qiagen
5.12.1 Qiagen Profile
5.12.2 Qiagen Main Business
5.12.3 Qiagen IVD Products, Services and Solutions
5.12.4 Qiagen IVD Revenue (US$ Million) & (2018-2023)
5.12.5 Qiagen Recent Developments
5.13 Diasorin
5.13.1 Diasorin Profile
5.13.2 Diasorin Main Business
5.13.3 Diasorin IVD Products, Services and Solutions
5.13.4 Diasorin IVD Revenue (US$ Million) & (2018-2023)
5.13.5 Diasorin Recent Developments
5.14 Ortho Clinical Diagnostics
5.14.1 Ortho Clinical Diagnostics Profile
5.14.2 Ortho Clinical Diagnostics Main Business
5.14.3 Ortho Clinical Diagnostics IVD Products, Services and Solutions
5.14.4 Ortho Clinical Diagnostics IVD Revenue (US$ Million) & (2018-2023)
5.14.5 Ortho Clinical Diagnostics Recent Developments
6 North America
6.1 North America IVD Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe IVD Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific IVD Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America IVD Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa IVD Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 IVD Market Dynamics
11.1 IVD Industry Trends
11.2 IVD Market Drivers
11.3 IVD Market Challenges
11.4 IVD Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
